boston pharmaceuticals gsk

News

GSK buys liver drug from Boston Pharmaceuticals

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their exclusivity periods.

· 19h · on MSN

Zacks Investment Research on MSN · 13h

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

· 1d · on MSN

GSK to buy liver disease drug for up to $2 billion

Pharmabiz21h

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

1don MSN

GSK to buy efimosfermin for up to $2 billion

British pharmaceutical giant GSK on Wednesday said it will buy efimosfermin, a phase III-ready potential specialty medicine ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

GSK buys liver drug from Boston Pharmaceuticals

Trending now